Free shipping on all orders over $ 500

Lurbinectedin

Cat. No. M10037

All AbMole products are for research use only, cannot be used for human consumption.

Lurbinectedin Structure
Synonym:

PM01183; PM-1183; LY-01017; Tryptamicidin

Size Price Availability Quantity
5mg USD 2300  USD2300 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Lurbinectedin, also known as PM01183, is a marine-derived covalent DNA binder with potential antineoplastic activity. Lurbinectedin (PM01183) covalently binds to residues lying in the minor groove of DNA, which may result in delayed progression through S phase, cell cycle arrest in the G2/M phase and cell death. Lurbinectedin significantly inhibits tumor growth in a mouse CCC cell xenografts.

Protocol (for reference only)
Cell Experiment
Cell lines CCC cells
Preparation method CCC cells (2×105) were incubated with lurbinectedin at the indicated concentrations for 48 hours. The cells were then fixed with 75% ethanol overnight at -20°C and stained with propidium iodide (PI; 50 μg/mL) in the presence of RNase A (100 μg/mL; Roth) for 60 minutes at 4°C. In each experiment, the cell cycle distribution was determined by analyzing 10,000 cells using a FACScan flow cytometer and Cell Quest software (Becton Dickinson, NJ, USA), as reported previously.
Concentrations -
Incubation time 48 hours
Animal Experiment
Animal models Five- to 7-week-old nude mice injected RMG1 cells
Formulation -
Dosages 0.180 mg/kg
Administration i.v. administered each week for 6 weeks
Chemical Information
Molecular Weight 784.87
Formula C41H44N4O10S
CAS Number 497871-47-3
Solubility (25°C) DMSO 1 μmol/L
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Ryoko Takahashi, et al. PLoS One. Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

[2] J F M Leal, et al. Br J Pharmacol. PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity

Related DNA/RNA Synthesis Products
Dencatistat

Dencatistat (P115) is an inhibitor of Cytidine Triphosphate Synthase 1 (CTPS1) with an IC50 value of ≤ 0.1 μM.

Antipain dihydrochloride

Antipain dihydrochloride is a protease inhibitor. Antipain dihydrochloride inhibits N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced transformation and increases chromosomal aberrations. Antipain dihydrochloride also restricts uterine DNA synthesis and function in mice.

Tetrahydrouridine

Tetrahydrouridine (THU) is potent inhibitor of cytidine deaminase (CDA), which competitively blocks the enzyme's active site more effectively than intrinsic cytidine.

Crisnatol

Crisnatol (BWA770U) is a member of the arylmethylaminopropanediol class of DNA intercalators. Crisnatol shows in vitro cytotoxicity against human breast cancer cells. Crisnatol (BWA770U) is also an orally active and anticancer agent.

Caf1-IN-1

Caf1-IN-1 is inhibitor for ribonuclease Caf1 with an IC50 of 0.59 µM. Caf1-IN-1 is also a weak inhibitor for poly(A)-specific ribonuclease (PARN) with IC50 of 23.9 µM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Lurbinectedin, PM01183; PM-1183; LY-01017; Tryptamicidin supplier, DNA/RNA Synthesis, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.